RECOMBINATE 500 IU

Država: Izrael

Jezik: angleščina

Source: Ministry of Health

Aktivna sestavina:

COAGULATION FACTOR VIII RECOMBINANT 500 IU/VIAL

Dostopno od:

TEVA MEDICAL MARKETING LTD.

Koda artikla:

B02BD05

Farmacevtska oblika:

POWDER FOR SOLUTION FOR INJECTION

Pot uporabe:

I.V

Izdeluje:

BAXTER S.A., BELGIUM

Terapevtska skupina:

COAGULATION FACTOR VII

Terapevtske indikacije:

The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.

Datum dovoljenje:

2010-07-01